| Ivan Trigueros, | |
|
350 Kresge Ln, Sparks, NV 89431-6435 | |
| (775) 359-9200 | |
| Not Available |
| Full Name | Ivan Trigueros |
|---|---|
| Gender | Male |
| Speciality | Case Manager/care Coordinator |
| Location | 350 Kresge Ln, Sparks, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710291653 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TR0400X | Psychologist - Rehabilitation | (* (Not Available)) | Secondary |
| 171M00000X | Case Manager/care Coordinator | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ivan Trigueros, 190 Bartlett St, Reno, NV 89512-2203 Ph: (775) 412-1646 | Ivan Trigueros, 350 Kresge Ln, Sparks, NV 89431-6435 Ph: (775) 359-9200 |
News Archive
InSysBio continues to investigate the mechanisms underlying Alzheimer's disease using the quantitative systems pharmacology modeling approach. The part of QSP model describing tau protein was published in the PLOS ONE journal. This is one of more than dozen InSysBio publications in AD area during last seven years.
The Seattle Children's Hospital and Gemalto, the world leader in digital security, today announced that Seattle Children's Hospital has implemented Gemalto's Protiva security solutions, including the Strong Authentication Server, two factor authentication devices and technical support services, to securely access its servers, networks and VPNs.
Connecticut Gov. Jodi Rell (R) on Monday released letters from two insurance companies that raised concerns about the cost of legislation that would allow workers at small businesses, municipalities and not-for-profit groups to join the state employee health insurance pool, the Hartford Courant reports.
The link between life events and mood episodes in patients with bipolar disorder is bidirectional, with positive and negative life events having different effects, report researchers.
Somaxon Pharmaceuticals, Inc. today announced that it is offering to sell up to 4,000,000 shares of its common stock in an underwritten public offering. Jefferies & Company, Inc. is acting as sole book-running manager in the offering. The co-manager in the offering is Oppenheimer & Co. Inc. Somaxon expects to grant the underwriters an option to purchase up to an additional 600,000 shares of common stock to cover overallotments of shares, if any.
› Verified 5 days ago